These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 523338)

  • 1. Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.
    Harsing LG; Magyar K; Tekes K; Vizi ES; Knoll J
    Pol J Pharmacol Pharm; 1979; 31(4):297-307. PubMed ID: 523338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG; Vizi ES
    Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
    Zsilla G; Földi P; Held G; Székely AM; Knoll J
    Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medicamentous strategy for improving the quality of life in the senescence].
    Knoll J
    Wien Med Wochenschr Suppl; 1986; 98():1-18. PubMed ID: 3097965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K; Tóthfalusi L; Gaál J; Magyar K
    Pol J Pharmacol Pharm; 1988; 40(6):653-8. PubMed ID: 3152003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Takemura M
    Pharmacol Biochem Behav; 2005 Nov; 82(3):488-94. PubMed ID: 16298423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP; Lamensdorf I; Armoni T
    Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Ca2+ in dopamine release in striatal rat slices by PF9601N and L-deprenyl.
    Pérez V; Pastó M; Unzeta M
    Neurobiology (Bp); 2000; 8(3-4):237-42. PubMed ID: 11225514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of (-)deprenyl.
    Knoll J
    J Neural Transm Suppl; 1986; 22():75-89. PubMed ID: 3097262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J; Yasar S; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL; Hashim A; Lajtha A; Sershen H
    J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover.
    Cohen G; Spina MB
    Ann Neurol; 1989 Nov; 26(5):689-90. PubMed ID: 2510589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S; Wu CF; Fusi R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregular chronic stress related selective presynaptic adaptation of dopaminergic system in rat striatum: effects of (-)deprenyl and amitriptyline.
    Tekes K; Tothfalusi T; Magyar K
    Acta Physiol Pharmacol Bulg; 1986; 12(4):21-8. PubMed ID: 3107343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.